buy

Our new stock in the portfolio has retreated from its recent 52-week high; so we buy more.

[ad_1] We buy 300 shares of Bristol-Myers Squibb at about $58 each. After Wednesday's transaction, Jim Cramer's Charitable Trust will…

5 months ago